Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SECNOL (secnidazole)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SECNOL (secnidazole)

Medicine - Posted on Dec 05 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • secnidazole
history (4)
  • 11/21/18

    SECNOL (secnidazole)

    Maintien du remboursement dans les mêmes conditions.
    icône flèche
  • 1/11/17

    SECNOL (secnidazole)

    Avis favorable à la prise en charge dans les vaginoses bactériennes
    CAV :
    54321
    icône flèche
  • 10/2/13

    SECNOL (secnidazole)

    SECNOL (secnidazole)
    icône flèche
  • 12/10/08

    SECNOL (secnidazole)

    SECNOL (secnidazole)
    icône flèche
Technical information
ATC code
  • P01AB07
Manufacturer
IPRAD
Presentation

SECNOL 2 g, granulés en sachet-dose (code CIS : 63820798) 1 sachet de 4,224 g - Code CIP : 3400933370718

All our publications
    Bacterial infections Drug therapy Esophageal and gastrointestinal diseases Female genital diseases Liver diseases Parasitic diseases and mycoses Urethral diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
G6SUd8PVPFe7nCS8